Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

57.76 UNCHANGED
Streaming Delayed Price Updated: 5:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
67 68 Next >
Bristol-Myers Squibb Unusual Options Activity
Via Benzinga
Survival Rates Improve with SELLAS's New Treatment for Severe Lung Cancer, Phase 1 Study Shows
SELLAS Life Sciences Group Inc (NASDAQ: SLS) released topline data from a Phase 1 trial of its lead clinical candidate, galinpepimut-S (GPS), combined with Bristol Myers Squibb Co (NYSE: BMY) nivolumab... 
Via Benzinga
Analyst Expectations for Bristol-Myers Squibb's Future
Via Benzinga
Fresh Blood: 3 Stocks Ready to Rally Under New CEOs
Here are three companies with new CEOs that could rally in the year ahead as new management shakes things up. 
Via InvestorPlace
Bristol Myers Squibb Receives European Commission Approval of CAMZYOS® (mavacamten), for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)
From Bristol Myers Squibb
Via Business Wire
2 Stocks to Buy With $100 and Hold Forever
Both companies are leaders in industries that have excellent growth prospects. 
Via The Motley Fool
3 Bargain Stocks to Buy on the Dip
These stocks should be poised to rebound. 
Via The Motley Fool
2 Low-Priced Stocks That Could Make You Richer
These two low-priced healthcare stocks could skyrocket within the next 12 months. 
Via The Motley Fool
3 Healthcare Stocks That Are Too Cheap to Ignore
Each of these companies is trading at a valuation well below those of its industry peers. 
Via The Motley Fool
Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows
Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows 
Via News Direct
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity
Via Benzinga
Bristol Myers' Opdivo/Chemo Shows Durable Results At Four Years In Lung Cancer Patients
Via Benzinga
I'm Buying These 3 Resilient Stocks During a Bear Market
Be ready for the next bear market with stocks that bounce back fast. 
Via The Motley Fool
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2038?
The healthcare company is already almost halfway there. 
Via The Motley Fool
7 Healthcare Stocks to Make You the Millionaire Next Door
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy. 
Via InvestorPlace
What's Going On With TRACON Pharmaceuticals Shares Today
TRACON Pharmaceuticals (NASDAQ: TCON) shares are trading lower Thursday morning after the company released the results of a six-month independent data monitoring committee (IDMC) review for the... 
Via Benzinga
3 AI Stocks That Could Skyrocket Your Wealth
AI is poised to greatly increase the top and bottom lines of many companies, making many AI stocks very attractive at this point. 
Via InvestorPlace
Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel) Delivers Deep and Durable Responses in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma in TRANSCEND Clinical Trials Presented at ICML 2023
From Bristol Myers Squibb
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label
From Bristol Myers Squibb
Via Business Wire
Negotiation or Coercion? Big Pharma and US Chamber of Commerce Tackle Government on Drug Prices
The U.S. Chamber of Commerce has filed a lawsuit against the federal government, challenging a recent law that grants Medicare the authority to negotiate drug prices with pharmaceutical companies. 
Via Benzinga
This Drug Candidate Could Be a Winner for Bristol Myers
Bristol Myers' lung cancer drug candidate could be just months away from U.S. Food and Drug Administration approval. 
Via The Motley Fool
Bristol Myers Squibb Receives U.S. FDA Approval of New State-of-the-Art Cell Therapy Manufacturing Facility in Devens, Massachusetts
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb to Report Results for Second Quarter 2023 on July 27, 2023
From Bristol Myers Squibb
Via Business Wire
Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It 'Extortion'
Merck & Co Inc (NYSE: MRK) has reportedly filed a lawsuit against the U.S. government to halt implementing the Medicare drug price negotiation program outlined in the Inflation Reduction Act (IRA).  
Via Benzinga
Chipotle, Bristol-Myers Squibb, Corteva And A Healthcare Giant On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named CVS Health Corporation (NYSE: CVS) 
Via Benzinga
Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
From Bristol Myers Squibb
Via Business Wire
Biotechs Zeroing In on Developing Breakthrough Therapeutics for Metastatic Breast Cancer
EQNX::TICKER_START (NASDAQ:ONCY),(NASDAQ:GILD),(NASDAQ:RAIN),(NASDAQ:CNSP),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
3 Dividend Stocks You Can Buy Without Any Hesitation
The choices are easy with these stocks. 
Via The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Big Pharma is facing a patent cliff that could siphon off billions in revenue. 
Via Investor's Business Daily
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
67 68 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.